GH response to GH-releasing hormone (GHRH) in Alzheimer and vascular dementia. Relation with somatostatin cerebrospinal levels

Annales d'Endocrinologie

Volumn 57, Issue 2, 1996, Pages 107-110

  Gomez J M ^a,b   Aguilar, M ^a   Navarro, Ma ^a   Ortola J ^a   Soler, J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b NONE   (Spain)

Author keywords

Alzheimer's disease; dementia; GH; GH releasing hormone; somatostatin; vascular dementia

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOSTATIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIINFARCT DEMENTIA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA, VASCULAR; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; SOMATOSTATIN;

EID: 0029992854     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. ATACK JR, BEAL MF, MAY C et al. Cerebrospinal fluid somatostatin and neuropeptide Y. Arch Neurol 1988 ; 45 : 269-74.
2. CACABELOS R, NIIGAWA HI, KEMURA T et al. GHRH-induced GH response in patients with senile dementia of the Alzheimer type. Acta endocrinol 1988 ; 177 : 295-301.
3. DAVIDSON M, DAVIS BM, BASTIAENS L. Growth hormone response 10 edrophonium in patients with Alzheimer's disease and normal subjects. Am J Psychiatr 1988 ; 145 : 1007-9.
4. DAVIS P, KATZMAN R, TERRY RD. Reduced somatostatin -like, immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 1980 ; 288 : 279-80
5. DEVESA J, LIMA L, Lois C et al Reasons for the variability in growth hormone (GH) responses to GHRH challenge ; the endogenous hypothalamic-somatotroph rythm (HSR). Clin Endocrinol 1989 ; 30 : 367-78
6. Diagnostic and Statistical Manual of Mental Disorders (3d edition, revised). Washington DC. Am Psychiat Assoc 1987.
7. DORAISWAMY PM, KRISHNAN KRR, NEMEROFF CB. Neuropetides and neurotransmitters in Alzheimer's disease : focus on corticotrophin releasing factor. Balliere's Clinics in Endocrinology and Metabolism 1991 ; 5 . 59-77.
8. FRANCIS PT, BOWEN DM, NEARY D, PALO J, WIKSTROM J, OLNEY J. Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients. Neurobiology and Aging 1984 ; 5 : 83-186
9. FERRIER IN, CROSS AD, JOHNSON JA et al. Neuropeptides in Alzheimer's type dementia. J Neurol Sci 1983 ; 62 : 159-70.
10. HOLSTEIN MF, FOLSTEIN SF, MCHUGH PR. Mini-mental state. J Psychiatr Research 1975 ; 12 : 189-98
11. GOTTFRIES CG Neurochemical aspects of dementia disorders. Dementia 1990 ; 1 : 56-64.
12. HACHINSKI VC, LASSEN NA, MARSHALL J. Multiinfart dementia. A cause of mental deterioration in the elderly. Lancet 1975 ; 2 : 207-10.
13. MARTIN JB, REICHLIN S. Clinical implications of neuropeptides in neurologic disorders. (ed. J.B. Martin, S. Reichlin S, In Clin Neuroendocrinol 1987 ; 607-36. F.A. Davis Company, Philadelphia.
14. MCKHANN G, DRACHMAN D, HOLSTEIN M, KATZMAN R, PRICE F, STADLAN EM. Clinical diagnosis of Alzheimer's disease : report of the NLNCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984 ; 34 : 485-90.
15. NAVARRO MA, MORATÓ J, ROSEL P, GÓMEZ JM. Somatostain in diabetes. Clin Chemistr 1983 , 29 : 2118-9.
16. NEMEROFF CA, KRISHANAN RR, BELKIN BM et al. Growth hormone response to growth hormone releasing factor in Alzheimer's disease and normal subjects. Neuroendocrinology 1989 ; 50 : 663-6
17. RASKIND MA, RESKIND ER, LAMPE TH, RIZZE SC, TABORSKY GJ, DORSA D. Cerebrospinal fluid vasopresin, oxytocin, somatostatin and B-endorfin in Alzheimer's disease Archives Geriatric Psychiatry 1986 ; 45 : 382-8.
18. SOINEN HS, JOLKKONEN JT, REINIKAIMEN KJ, HALONEN TO, RIEKKINEN PJ. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neurol Sci 1984 ; 63 : 167-72
19. SORENSEN KV, KRISTENSEN SE, HANSEN J. INGERSLER J, PEDERSEN E., ORSKOV H. The origen of cerebrospinal fluid somatostatin. Hypothlamic or disperse central nervous system secretion ? Neuroendocrinology 1981 ; 32 : 335-8.
20. SPARKS DL, DEKOSKY ST, MARKESBERY WR. Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus. Arch Neurol 1988 ; 45 : 994-9.
21. STEARDO L, TAMMINGA CA, BARONE P et al CSF somatostatin immunoreactivity and GH plasma levels in Alzheimer's disease. Neuroendocrinology Letters 1984 ; 6 : 291-4.
22. TANNENBAUM GS, LING N. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in the generation of the ultradian rythm of GH secretion. Endocrinology 1984 ; 115 : 1952-5.
23. THORNER MO, SPIESS J, VANCE ML et al. Human pancreatic growth hormone-releasing factor selectivity stimulates growth hormone secretin in man. Lancet 1983 ; 1 : 24-8.
24. WADE JPH, MIRSEN TR, HACHINSKI VC, FISMAN M, LAN C, MERSKEY H The clinical diagnosis of Alzheimer's disease. Arch Neurol 1987 ; 44 : 24-9.